Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289588 · ClinicalTrials.gov registry record · NA
An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
A NA study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
NCT00289588 is a NA study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 3,000 participants.
The verdict
NCT00289588, a NA study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine if applying mupirocin into soldiers noses who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) will reduce infections in them and their cohort of fellow soldiers.
Interventions
- DRUG Mupirocin (drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2005-01 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289588
The ClinicalTrials.gov registry entry for NCT00289588 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mupirocin (drug) is the first listed.
NCT00289588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00289588 about?
NCT00289588 is a clinical study titled "An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers". The main purpose of this study is to determine if applying mupirocin into soldiers noses who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) will reduce infections in them and their cohort of fellow soldiers.
What is the current status of trial NCT00289588?
This trial is currently completed. It is a NA study. The enrollment target is 3,000 participants. The study started on 2005-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00289588?
The interventions under investigation include: Mupirocin (drug) (DRUG).
Who is sponsoring clinical trial NCT00289588?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.